Pignata, S., S. C. Cecere, and M. Di Maio. “Bevacizumab As First-Line Treatment of Ovarian Cancer: Strengths and Weaknesses of Subgroup Analyses:  ”. Cancer Breaking News, vol. 4, no. 1, Mar. 2016, pp. 45-47, doi:10.19156/cbn.2016.0009.